Search our news, events & opinions

30 March 2020 0 Comments
Posted in Corporate, Opinion

Business alert: ICSA issues further guidance on AGMs during the coronavirus outbreak

Author headshot image Posted by , Partner

The Chartered Governance Institute (“ICSA”) has now published further guidance for listed companies on holding valid AGMs in light of the government imposed stay at home measures.

AGM during coronavirus

The guidance includes:

1.   Can AGMs be validly held? Yes, but general meetings will need to be held in a different way whilst the stay at home measures are in force.

2.   Are shareholders able to attend meetings? Shareholders will not be able to attend general meetings whilst the stay at home measures are in force. Their attendance (other than as required to form a quorum) will not fall within the “essential for work purposes” category. Any notice of an AGM should make clear that shareholders may not attend in person, will be refused entry and should vote by proxy.

3.   Quorum. The quorum should be capable of satisfaction by two director and/or employee shareholders attending with resolutions being passed by proxy votes in conjunction with the votes of those director and/or employee shareholders attending. The number of individuals physically present should be kept to an absolute minimum.

4.   Chair. The proxy form should appoint the chairman of the meeting as proxy (rather than a named individual who may be unable to attend).

5.   Venue. Where a meeting has been convened and the venue subsequently becomes unavailable, if the articles of association permit the board to move or postpone the meeting the board should consider relocating it to an alternative location. Where the articles do not permit the board to postpone or relocate the meeting, the meeting should be adjourned to an alternative venue. This can be done by those planning to attend to form the quorum (being the two director and/or employee shareholders) attending the unavailable venue and triggering the adjournment or relocation.

The full guidance is available here.

Our Corporate and Commercial teams are monitoring the effects of the COVID-19 crisis and will continue to bring you updates as we learn more. Contact us on:

0800 923 2073     Email

Leave a comment

Thank you for choosing to leave a comment. Please keep in mind that comments are moderated and please do not use a spammy keyword or a domain as your name or it will be deleted.





Keeping you informed about Corporate news, events and opinion.


T: 01225 730 170 (DDI)

Search our news, events & opinions